Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Guilhot

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Haematology and Blood Transfusion|January 1, 1987
Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized studyM Marty, E Lepage, H Guy, et al.
Leukemia|November 1, 1992
Polymerase chain reaction detection of residual disease in chronic myeloid leukemia patients in complete cytogenetic remission under interferon with or without chemotherapyF X Mahon, L Daheron, M C Malinge, et al.
Bone Marrow Transplantation|January 1, 1991
Intensive therapy for high grade multiple myeloma (MM)J L Harousseau, N Milpied, J P Jouet, et al.
British Journal of Haematology|August 1, 1991
Natural-killer cell activity and cytogenetic response in chronic myelogenous leukemia treated with alpha-interferonA Meseri, V Delwail, F X Mahon, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Acute leukemia with translocation (8;16)]J Tanzer, A Brizard, F Guilhot, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Haematology and Blood Transfusion|January 1, 1987
Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized studyM Marty, E Lepage, H Guy, et al.
Leukemia|November 1, 1992
Polymerase chain reaction detection of residual disease in chronic myeloid leukemia patients in complete cytogenetic remission under interferon with or without chemotherapyF X Mahon, L Daheron, M C Malinge, et al.
Bone Marrow Transplantation|January 1, 1991
Intensive therapy for high grade multiple myeloma (MM)J L Harousseau, N Milpied, J P Jouet, et al.
British Journal of Haematology|August 1, 1991
Natural-killer cell activity and cytogenetic response in chronic myelogenous leukemia treated with alpha-interferonA Meseri, V Delwail, F X Mahon, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
[Acute leukemia with translocation (8;16)]J Tanzer, A Brizard, F Guilhot, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
Bone Marrow Transplantation|June 1, 1995
Recombinant alpha-interferon as treatment for chronic myelogenous leukemia in relapse after allogeneic bone marrow transplantation: a report from the Société Française de Greffe de MoelleA Pigneux, A Devergie, M Pochitaloff, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Bone Marrow Transplantation|May 1, 1996
Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemiaH Heimpel, N C Allan, M Baccarani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
High-dose salvage chemotherapy without bone marrow transplantation for adult patients with refractory Hodgkin's diseaseJ M Tourani, R Levy, P Colonna, et al.
Pageof 16